Sign in
Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost
Journal article   Open access  Peer reviewed

Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost

Ryan Whitney, Vlatimil Vàlek, Joan Falco Fages, Agustin Garcia, Govindarajan Narayanan, Cliff Tatum, Mike Hahl and Robert C. G Martin
The oncologist (Dayton, Ohio), Vol.16(5), pp.594-601
2011-05
PMCID: PMC3228197
PMID: 21508068

Abstract

Chemoembolization Doxorubicin Endocrinology Liver directed therapy Metastatic neuroendocrine Yttrium-90
The safety, efficacy, and cost of selective internal radiation and drug-eluting bead therapy were compared.
url
https://doi.org/10.1634/theoncologist.2010-0292View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.195 Neuroendocrine & Intestinal Disorders
1.195.565 Neuroendocrine Tumors
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details